Role of Carma1 in Inflammatory Lung Disease
Carma1 在炎症性肺病中的作用
基本信息
- 批准号:7771637
- 负责人:
- 金额:$ 41.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2012-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigensAsthmaBackcrossingsBiochemical GeneticsBiologyCell physiologyChronic DiseaseCollectionComplexDataDevelopmentDiseaseExperimental DesignsFamilyGenerationsGenesGlucocorticoidsGoalsHealthHost DefenseImmune responseImmunosuppressive AgentsInfectionInflammationInflammatoryLungLung diseasesLymphocyteMediatingMediator of activation proteinMemoryModelingMolecularMusMutant Strains MiceMutationOutcome StudyPathogenesisPathway interactionsPharmaceutical PreparationsPhosphorylationPhosphorylation SitePhosphotransferasesPlayPneumoniaPopulationProcessProtein FingerprintsProteinsProteomicsReceptor SignalingRegulationRegulatory T-LymphocyteResolutionRoleScaffolding ProteinSerineSignal PathwaySignal TransductionStudy SectionT cell differentiationT memory cellT-Cell ActivationT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTestingTh2 CellsTransgenic MiceTransgenic Organismsairway inflammationallergic airway inflammationantigen challengebasecandidate identificationeffective therapyimmune functionin vivoin vivo Modelinsightintermolecular interactionmouse modelnew therapeutic targetnovelpromoterpublic health relevancetranscription factortransmission process
项目摘要
DESCRIPTION (provided by applicant): NF-?B is a transcription factor crucial for regulating the expression of many genes involved in inflammation, and for the development of T cell-mediated inflammatory diseases such as asthma. Recent studies have demonstrated that the CARMA1-Bcl10- MALT1 signaling pathway is essential for TCR mediated NF-?B activation. Consistent with this, we have demonstrated that CARMA1 is essential for the development of allergic airway inflammation through its role in T lymphocytes. Furthermore, we have shown that CARMA1 dependent signal transmission is regulated by sequential phosphorylation by kinases. However, the exact mechanism of CARMA1 regulation in vivo remains elusive. In four interrelated aims, we will explore the regulation of CARMA1 in T cells and determine the effect of disruption of CARMA1 expression after the establishment of Th2-type pulmonary inflammation. The experimental design emphasizes the use of in vivo models of pulmonary inflammation as well as conventional approaches based on the analysis of interacting proteins using biochemical and genetic studies. The outcome of these studies will provide insight into NF-?B signaling in health and pulmonary inflammation, and may identify novel therapeutic targets. Aim 1: To characterize the role of CARMA1 in T lymphocytes during the development of allergic airway inflammation in a murine model of asthma. Aim 2: To characterize the role of CARMA1 in regulatory T cell (Treg) development and function in a murine model of asthma. Aim 3: To determine the in vivo role of serine phosphorylation of CARMA1 in lymphocyte signaling by transgenic analysis. Aim 4: To delineate novel components of signaling pathways activated by CARMA1 in T lymphocytes. PUBLIC HEALTH RELEVANCE. Asthma remains one of the most common chronic diseases in the world. Although effective therapy is achieved by the use of glucocorticoids and immunosuppressants, these drugs suppress a broad spectrum of immune function. In this proposal we investigate a protein involved in the development of asthma in a mouse model of disease. The information obtained from our proposed studies may allow us to develop more specific therapy for this disorder.
描述(由申请人提供):NF-κB是一种转录因子,对于调节与炎症有关的许多基因的表达以及对于T细胞介导的炎症性疾病(例如哮喘)的发展至关重要。最近的研究表明,CARMA1-Bcl10-MALT1 信号通路对于 TCR 介导的 NF-κB 激活至关重要。与此相一致的是,我们已经证明 CARMA1 通过其在 T 淋巴细胞中的作用对于过敏性气道炎症的发生至关重要。此外,我们已经证明 CARMA1 依赖性信号传递是通过激酶的顺序磷酸化来调节的。然而,CARMA1 体内调节的确切机制仍不清楚。在四个相互关联的目标中,我们将探索 T 细胞中 CARMA1 的调节,并确定 Th2 型肺部炎症建立后 CARMA1 表达破坏的影响。实验设计强调使用肺部炎症体内模型以及基于生化和遗传学研究相互作用蛋白质分析的传统方法。这些研究的结果将深入了解健康和肺部炎症中的 NF-κB 信号传导,并可能确定新的治疗靶点。目标 1:表征小鼠哮喘模型中过敏性气道炎症发展过程中 CARMA1 在 T 淋巴细胞中的作用。目标 2:在小鼠哮喘模型中表征 CARMA1 在调节性 T 细胞 (Treg) 发育和功能中的作用。目标 3:通过转基因分析确定 CARMA1 丝氨酸磷酸化在淋巴细胞信号传导中的体内作用。目标 4:描绘 T 淋巴细胞中 CARMA1 激活的信号通路的新成分。公共卫生相关性。哮喘仍然是世界上最常见的慢性疾病之一。尽管使用糖皮质激素和免疫抑制剂可以实现有效的治疗,但这些药物会抑制广泛的免疫功能。在这项提案中,我们研究了一种与小鼠疾病模型中哮喘发展有关的蛋白质。从我们拟议的研究中获得的信息可能使我们能够针对这种疾病开发出更具体的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin David Medoff其他文献
Benjamin David Medoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin David Medoff', 18)}}的其他基金
Trained Immunity in the Airway Mucosa Differentiates Asthma from Allergy Alone
气道粘膜经过训练的免疫力可将哮喘与单纯过敏区分开来
- 批准号:
10673238 - 财政年份:2023
- 资助金额:
$ 41.17万 - 项目类别:
Targeting durotaxis in lung injury and fibrosis
靶向肺损伤和纤维化中的杜罗轴
- 批准号:
10364927 - 财政年份:2021
- 资助金额:
$ 41.17万 - 项目类别:
Targeting durotaxis in lung injury and fibrosis
靶向肺损伤和纤维化中的杜罗轴
- 批准号:
10532249 - 财政年份:2021
- 资助金额:
$ 41.17万 - 项目类别:
Targeting the ADAM10-sEphrin-B2 pathway in pulmonary fibrosis
靶向 ADAM10-sEphrin-B2 通路治疗肺纤维化
- 批准号:
10599961 - 财政年份:2019
- 资助金额:
$ 41.17万 - 项目类别:
Targeting the ADAM10-sEphrin-B2 pathway in pulmonary fibrosis
靶向 ADAM10-sEphrin-B2 通路治疗肺纤维化
- 批准号:
10372067 - 财政年份:2019
- 资助金额:
$ 41.17万 - 项目类别:
Role of Carma1 in Inflammatory Lung Disease
Carma1 在炎症性肺病中的作用
- 批准号:
7591206 - 财政年份:2008
- 资助金额:
$ 41.17万 - 项目类别:
Role of Carma1 in Inflammatory Lung Disease
Carma1 在炎症性肺病中的作用
- 批准号:
7591206 - 财政年份:2008
- 资助金额:
$ 41.17万 - 项目类别:
Role of Carma1 in Inflammatory Lung Disease
Carma1 在炎症性肺病中的作用
- 批准号:
7466234 - 财政年份:2008
- 资助金额:
$ 41.17万 - 项目类别:
相似国自然基金
嗜碱性粒细胞参与抗原诱发的“特应性皮炎-哮喘”过敏进程的作用和机制研究
- 批准号:81972930
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
sPLA2-X及其信号通路在腺病毒载体携带结核抗原对支气管哮喘免疫保护中的作用及机制研究
- 批准号:81860008
- 批准年份:2018
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
IL-25作为始动因子对过敏性哮喘嗜酸粒细胞抗原递呈作用的研究
- 批准号:81870021
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
靶向抗原特异性T细胞融合蛋白疫苗的构建及其抑制过敏性哮喘的机理研究
- 批准号:81701589
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
IL-35依赖的免疫调节T细胞iT(R)35对抗原特异性记忆T细胞的抑制在过敏性哮喘特异性免疫治疗中的作用和机制研究
- 批准号:81700037
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel humanized mouse model of mucosal immunity
新型人源化小鼠粘膜免疫模型
- 批准号:
10591854 - 财政年份:2023
- 资助金额:
$ 41.17万 - 项目类别:
Expecting Mothers' Study of Consumption or Avoidance of Peanut and Egg (ESCAPE)
准妈妈食用或避免花生和鸡蛋的研究(ESCAPE)
- 批准号:
10733927 - 财政年份:2023
- 资助金额:
$ 41.17万 - 项目类别:
Defining the development of tissue-resident memory Th2 cells in allergic asthma
定义过敏性哮喘中组织驻留记忆 Th2 细胞的发育
- 批准号:
10501568 - 财政年份:2022
- 资助金额:
$ 41.17万 - 项目类别:
Development of B cell memory in allergic asthma
过敏性哮喘中 B 细胞记忆的发展
- 批准号:
10503760 - 财政年份:2022
- 资助金额:
$ 41.17万 - 项目类别:
Defining the development of tissue-resident memory Th2 cells in allergic asthma
定义过敏性哮喘中组织驻留记忆 Th2 细胞的发育
- 批准号:
10670871 - 财政年份:2022
- 资助金额:
$ 41.17万 - 项目类别: